Valora Therapeutics

BiotechnologySeedLa Jolla, USvaloratherapeutics.com

Latest round

Seed

Last raised

Jul 2024

Total raised

$13M

Investors

5

About Valora Therapeutics

a. Valora Therapeutics is a biotechnology company that specializes in immunotherapy development. In November 2024, Valora Therapeutics Inc. As of November 2023, Miguel Garcia-Guzman is the CEO of the company. Valora Therapeutics specializes in immunotherapy solutions through its proprietary AbLec™ platform, which focuses on decoding the complex sugar code involved in cellular and immune interactions. The platform addresses deficiencies in immune communication prevalent in various diseases, offering a novel approach to treatment. By leveraging advancements in glycobiology, Valora Therapeutics aims to develop therapies that can significantly improve patient outcomes across a broad range of conditions, specifically for patients suffering from immune-related diseases, including cancer and autoimmune disorders.

Who invested in Valora Therapeutics

5 investors across 1 round

See all investors in Valora Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jul 9, 2024

    Amount

    $13M

    Investors

    Locked

Questions about Valora Therapeutics

Who invested in Valora Therapeutics?

Valora Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Valora Therapeutics raised?

Valora Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Valora Therapeutics last raise money?

Valora Therapeutics's most recent round on record is a Seed, in Jul 2024.

What does Valora Therapeutics do?

Valora Therapeutics is a biotechnology company.

Where is Valora Therapeutics headquartered?

Valora Therapeutics is headquartered in La Jolla, US.

Which VCs invest in companies like Valora Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Valora Therapeutics's stage. Their profiles are linked below.

Raising like Valora Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.